Generic drugmaker Sandoz files anti-dumping complaint over Chinese antibiotic imports
May 28, 2026
Sandoz filed an anti-dumping complaint with the EU Commission against Chinese amoxicillin imports, citing market-distorting practices. The company warns Europe risks losing antibiotic manufacturing capacity as 90% of global active ingredients are now produced outside Europe.